114 related articles for article (PubMed ID: 22130178)
21. Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.
Bowden CL; Myers JE; Grossman F; Xie Y
J Clin Psychiatry; 2004 May; 65(5):707-14. PubMed ID: 15163260
[TBL] [Abstract][Full Text] [Related]
22. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
23. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
[TBL] [Abstract][Full Text] [Related]
24. A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.
Janicak PG; Keck PE; Davis JM; Kasckow JW; Tugrul K; Dowd SM; Strong J; Sharma RP; Strakowski SM
J Clin Psychopharmacol; 2001 Aug; 21(4):360-8. PubMed ID: 11476119
[TBL] [Abstract][Full Text] [Related]
25. Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.
Arnold LE; Gadow KD; Farmer CA; Findling RL; Bukstein O; Molina BS; Brown NV; Li X; Rundberg-Rivera EV; Bangalore S; Buchan-Page K; Hurt EA; Rice R; McNamara NK; Aman MG
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):203-12. PubMed ID: 25885010
[TBL] [Abstract][Full Text] [Related]
26. Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trial.
Moosavi SM; Ahmadi M; Monajemi MB
Glob J Health Sci; 2014 Jul; 6(6):163-7. PubMed ID: 25363101
[TBL] [Abstract][Full Text] [Related]
27. Effect of comorbid anxiety on treatment response in bipolar depression.
Tohen M; Calabrese J; Vieta E; Bowden C; Gonzalez-Pinto A; Lin D; Xu W; Corya S
J Affect Disord; 2007 Dec; 104(1-3):137-46. PubMed ID: 17512607
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania.
Weiser M; Levi L; Levine SZ; Bialer M; Shekh-Ahmad T; Matei V; Tiugan A; Cirjaliu D; Sava C; Sinita E; Zamora D; Davis JM
Bipolar Disord; 2017 Jun; 19(4):285-294. PubMed ID: 28605109
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
[TBL] [Abstract][Full Text] [Related]
30. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
[TBL] [Abstract][Full Text] [Related]
31. Asenapine in clinical practice: preliminary results from a naturalistic observational study.
Gramaglia C; Rizza MC; Gattoni E; Gambaro E; Di Marco S; Coppola I; Rossi A; Jona A; Imperatori F; Prosperini P; Chieppa N; Binda V; Farruggio S; Grossini E; Zeppegno P
Riv Psichiatr; 2014; 49(6):241-6. PubMed ID: 25668625
[TBL] [Abstract][Full Text] [Related]
32. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.
Yatham LN; Grossman F; Augustyns I; Vieta E; Ravindran A
Br J Psychiatry; 2003 Feb; 182():141-7. PubMed ID: 12562742
[TBL] [Abstract][Full Text] [Related]
33. Risperidone: a review of its use in the treatment of bipolar mania.
Fenton C; Scott LJ
CNS Drugs; 2005; 19(5):429-44. PubMed ID: 15907153
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Risperidone and Quetiapine in Adolescents With Bipolar II Disorder Comorbid With Conduct Disorder.
Masi G; Milone A; Stawinoga A; Veltri S; Pisano S
J Clin Psychopharmacol; 2015 Oct; 35(5):587-90. PubMed ID: 26226481
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and management of anxiety in patients with bipolar disorder.
Kauer-Sant'Anna M; Kapczinski F; Vieta E
CNS Drugs; 2009 Nov; 23(11):953-64. PubMed ID: 19845416
[TBL] [Abstract][Full Text] [Related]
36. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
[TBL] [Abstract][Full Text] [Related]
37. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.
Gao K; Ganocy SJ; Conroy C; Brownrigg B; Serrano MB; Calabrese JR
Psychopharmacology (Berl); 2017 Aug; 234(15):2233-2244. PubMed ID: 28536866
[TBL] [Abstract][Full Text] [Related]
38. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
Maina G; Albert U; Rosso G; Bogetto F
J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
[TBL] [Abstract][Full Text] [Related]
39. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.
Bruggeman R; van der Linden C; Buitelaar JK; Gericke GS; Hawkridge SM; Temlett JA
J Clin Psychiatry; 2001 Jan; 62(1):50-6. PubMed ID: 11235929
[TBL] [Abstract][Full Text] [Related]
40. A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder.
Pavuluri MN; Henry DB; Carbray JA; Sampson GA; Naylor MW; Janicak PG
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):336-50. PubMed ID: 16768641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
